Janux Therapeutics Ownership | Who Owns Janux Therapeutics?
Janux Therapeutics Ownership Summary
Janux Therapeutics is owned by 58.70% institutional investors, 6.98% insiders, and 34.32% retail investors. Ra capital management is the largest institutional shareholder, holding 18.08% of JANX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.67% of its assets in Janux Therapeutics shares.
JANX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Janux Therapeutics | 58.70% | 6.98% | 34.32% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 11.19M | 18.08% | $273.48M |
| Fmr | 9.06M | 14.63% | $221.33M |
| Blackrock funding, inc. /de | 4.08M | 6.58% | $56.31M |
| Janus henderson group | 3.56M | 6.52% | $190.62M |
| Blackrock | 2.34M | 4.78% | $98.19M |
| Paradigm biocapital advisors lp | 2.92M | 4.72% | $71.37M |
| Vanguard group | 2.91M | 4.69% | $40.11M |
| Adage capital partners gp | 2.77M | 4.48% | $67.82M |
| Prosight management, lp | 2.39M | 3.86% | $33.02M |
| State street | 1.89M | 3.06% | $46.23M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Avalon ventures management | 53.30K | 9.17% | $1.30M |
| Prosight management, lp | 2.39M | 6.82% | $33.02M |
| Ra capital management | 11.19M | 3.37% | $273.48M |
| Bioimpact capital | 614.28K | 2.46% | $15.01M |
| Logos global management lp | 935.00K | 2.05% | $22.85M |
| Paradigm biocapital advisors lp | 2.92M | 2.03% | $71.37M |
| Cormorant asset management, lp | 850.00K | 1.43% | $20.77M |
| Orbimed advisors | 1.77M | 1.02% | $43.16M |
| Readystate asset management lp | 960.38K | 1.00% | $23.47M |
| Adar1 capital management | 351.03K | 0.81% | $8.58M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Prosight management, lp | 2.39M | 6.82% | 1.53M |
| Janus henderson group | 3.56M | 0.10% | 1.04M |
| Holocene advisors, lp | 1.02M | 0.17% | 1.02M |
| T. rowe price investment management | 972.69K | 0.01% | 972.69K |
| Blackrock | 2.34M | 0.00% | 650.02K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | - | - | -1.47M |
| Rtw investments, lp | - | - | -1.00M |
| Lord, abbett | - | - | -667.88K |
| Cormorant asset management, lp | 850.00K | 1.43% | -650.00K |
| First turn management | - | - | -639.70K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Holocene advisors, lp | 1.02M | 0.17% | 1.02M | $54.35M |
| T. rowe price investment management | 972.69K | 0.01% | 972.69K | $23.77M |
| Blue owl capital lp | 100.00K | 0.10% | 100.00K | $1.38M |
| Hrt financial lp | 63.54K | 0.00% | 63.54K | $876.00K |
| Ghost tree capital | 50.00K | 0.66% | 50.00K | $2.09M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Corecap advisors | -9.00 |
| Srs capital advisors | -14.00 |
| Stephens consulting | -15.00 |
| Capital performance advisors llp | -17.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 139 | -23.20% | 36,407,138 | -44.13% | 58 | 0.53% | 83 | 2.47% | 29 | -53.23% |
| Sep 30, 2025 | 172 | -1.71% | 64,553,591 | 1.68% | 104 | 0.99% | 79 | -14.13% | 59 | 15.69% |
| Jun 30, 2025 | 180 | -6.25% | 65,438,049 | -1.58% | 105 | 0.91% | 93 | -21.19% | 53 | 23.26% |
| Mar 31, 2025 | 7 | -96.93% | 3,447,727 | -94.63% | 5 | 0.04% | 5 | -96.82% | 1 | -97.73% |
| Dec 31, 2024 | 213 | 29.09% | 61,331,550 | 34.45% | 112 | 1.61% | 149 | 67.42% | 37 | -22.92% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 2.20M | 3.67% | 2.89K |
| Fidelity Growth Compy Commingled Pl O | 1.65M | 3.16% | 20.65K |
| Fidelity Growth Company Fund | 1.56M | 2.60% | -9.34K |
| Vanguard Total Stock Mkt Idx Inv | 1.18M | 1.98% | -26.09K |
| Vanguard US Total Market Shares ETF | 1.00M | 1.69% | 193.50K |
| iShares Russell 2000 ETF | 945.98K | 1.57% | - |
| Fidelity Select Health Care | 699.39K | 1.16% | - |
| Fidelity Small Cap Growth | 696.57K | 1.16% | - |
| US Small-Cap Growth II Equity Comp | 609.99K | 1.03% | 143.97K |
| SPDR® S&P Biotech ETF | 571.67K | 0.95% | 1.27K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 02, 2026 | Meyer Andrew Hollman | Chief Business Officer | Sell | $25.80K |
| Jan 02, 2026 | DiRaimondo Thomas | Chief Scientific Officer | Sell | $34.39K |
| Jan 02, 2026 | Campbell David Alan | President and CEO | Sell | $110.83K |
| Jan 02, 2026 | Winter Charles M. | Chief Technical Officer | Sell | $32.97K |
| Jan 02, 2026 | McIver Zachariah | Chief Medical Officer | Sell | $37.26K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 6 |
| 2025 Q4 | - | 4 |
| 2025 Q2 | - | 3 |
| 2025 Q1 | 4 | 11 |
| 2024 Q4 | 1 | 23 |
JANX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools